EIF5A2 抗体
(Eukaryotic Translation Initiation Factor 5A2 (EIF5A2))
mRNA-binding protein involved in translation elongation. Has an important function at the level of mRNA turnover, probably acting downstream of decapping. Involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity. Functions as a regulator of apoptosis. Mediates effects of polyamines on neuronal process extension and survival. May play an important role in brain development and function, and in skeletal muscle stem cell differentiation (By similarity).
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| EIF5A2 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| EIF5A2 抗体 | 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (AA 66-153) | 人 | 小鼠 Monoclonal |
|
|
|
| EIF5A2 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (AA 2-153) | 人 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (AA 1-153) | 人 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (AA 1-153) | 人 | 小鼠 Polyclonal |
|
|
|
| EIF5A2 抗体 (C-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (N-Term) | 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 兔, Hamster, 猴 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (AA 1-153) | 人 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (Internal Region) | 人 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (Internal Region) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (AA 16-153) | 人 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (AA 93-122) (PE) | 人 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (AA 93-122) (APC) | 人 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (AA 78-127) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (AA 93-122) | 人 | 兔 Polyclonal |
|
|
|
| EIF5A2 抗体 (AA 93-122) (Biotin) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 6G7
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
1 reference - 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1E7
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 66-153
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB34131
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 93-122, C-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 2-153
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-153
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-153
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-153
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Internal Region
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Internal Region
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 16-153
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 93-122
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 93-122
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 78-127
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 93-122
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 93-122
Latest Publications for our EIF5A2 抗体
: "A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer." in: Cancer research, Vol. 74, Issue 22, pp. 6671-81, (2014) (PubMed).
: "ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma." in: Cancer science, Vol. 105, Issue 4, pp. 490-7, (2014) (PubMed).
: "Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder." in: Cancer science, Vol. 100, Issue 5, pp. 896-902, (2009) (PubMed).
: "Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy." in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 18, Issue 2, pp. 400-8, (2009) (PubMed).
: "Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma." in: Gynecologic oncology, Vol. 112, Issue 2, pp. 314-8, (2009) (PubMed).
: "Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma." in: Human pathology, Vol. 39, Issue 1, pp. 80-6, (2007) (PubMed).
: "Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy." in: Journal of gastroenterology, Vol. 42, Issue 9, pp. 730-6, (2007) (PubMed).
: "Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells." in: The FEBS journal, Vol. 273, Issue 6, pp. 1102-14, (2006) (PubMed).
: "Nucleolar proteome dynamics." in: Nature, Vol. 433, Issue 7021, pp. 77-83, (2005) (PubMed).
: "Oncogenic role of eIF-5A2 in the development of ovarian cancer." in: Cancer research, Vol. 64, Issue 12, pp. 4197-200, (2004) (PubMed).
: "ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma." in: Cancer science, Vol. 105, Issue 4, pp. 490-7, (2014) (PubMed).
: "Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder." in: Cancer science, Vol. 100, Issue 5, pp. 896-902, (2009) (PubMed).
: "Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy." in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 18, Issue 2, pp. 400-8, (2009) (PubMed).
: "Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma." in: Gynecologic oncology, Vol. 112, Issue 2, pp. 314-8, (2009) (PubMed).
: "Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma." in: Human pathology, Vol. 39, Issue 1, pp. 80-6, (2007) (PubMed).
: "Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy." in: Journal of gastroenterology, Vol. 42, Issue 9, pp. 730-6, (2007) (PubMed).
: "Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells." in: The FEBS journal, Vol. 273, Issue 6, pp. 1102-14, (2006) (PubMed).
: "Nucleolar proteome dynamics." in: Nature, Vol. 433, Issue 7021, pp. 77-83, (2005) (PubMed).
: "Oncogenic role of eIF-5A2 in the development of ovarian cancer." in: Cancer research, Vol. 64, Issue 12, pp. 4197-200, (2004) (PubMed).
Aliases for EIF5A2 抗体
eukaryotic translation initiation factor 5A2 (EIF5A2) 抗体eukaryotic translation initiation factor 5A2 (eif5a2) 抗体
eukaryotic translation initiation factor 5A3 (LOC100499632) 抗体
eukaryotic translation initiation factor 5A2 (Eif5a2) 抗体
9630038B20 抗体
EIF-5A2 抗体
EIF5A 抗体
EIF5A2 抗体
eIF5AII 抗体
wu:fb05b06 抗体
wu:fc23f04 抗体
wu:fc61c10 抗体
zgc:55504 抗体
zgc:77429 抗体
您还需要查找其他产品吗？
You are here:
